Literature DB >> 1822781

Immunogold labelling of dystrophin in human muscle, using an antibody to the last 17 amino acids of the C-terminus.

M J Cullen1, J Walsh, L V Nicholson, J B Harris, E E Zubrzycka-Gaarn, P N Ray, R G Worton.   

Abstract

Immunolabelling with a 10 nm gold probe was used to localize dystrophin at the ultrastructural level in human skeletal muscle. The primary antibody was raised against a synthetic peptide containing the last 17 amino acids at the C-terminus of dystrophin. Using this antibody, labelling was almost entirely confined to a narrow band enclosing 40 nm either side of the plasma membrane and including the membrane itself. Histograms of the position of the gold probe relative to the plasma membrane showed modes lying over the membrane itself or the extracellular face of the membrane. One interpretation of these results is that the C-terminus of dystrophin is inserted in the plasma membrane alongside the glycoproteins with which it is tightly associated. Histograms of the distances between gold probes displayed modes at approximately 120 nm in both transverse and longitudinal sections suggesting that dystrophin forms a lattice-like network adjacent to the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1822781     DOI: 10.1016/0960-8966(91)90058-z

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  10 in total

1.  Contractile function, sarcolemma integrity, and the loss of dystrophin after skeletal muscle eccentric contraction-induced injury.

Authors:  Richard M Lovering; Patrick G De Deyne
Journal:  Am J Physiol Cell Physiol       Date:  2003-10-01       Impact factor: 4.249

2.  Are cysteine-rich and COOH-terminal domains of dystrophin critical for sarcolemmal localization?

Authors:  D Récan; P Chafey; F Leturcq; J P Hugnot; N Vincent; F Tomé; H Collin; D Simon; P Czernichow; L V Nicholson
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

3.  Visualization of the subsarcolemmal cytoskeleton network of mouse skeletal muscle cells by en face views and application to immunoelectron localization of dystrophin.

Authors:  C Berthier; J Amsellem; S Blaineau
Journal:  J Muscle Res Cell Motil       Date:  1995-10       Impact factor: 2.698

4.  Genetic correction of dystrophin deficiency and skeletal muscle remodeling in adult MDX mouse via transplantation of retroviral producer cells.

Authors:  A Fassati; D J Wells; P A Sgro Serpente; F S Walsh; S C Brown; P N Strong; G Dickson
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

5.  Dystrophin is phosphorylated by endogenous protein kinases.

Authors:  M Luise; C Presotto; L Senter; R Betto; S Ceoldo; S Furlan; S Salvatori; R A Sabbadini; G Salviati
Journal:  Biochem J       Date:  1993-07-01       Impact factor: 3.857

6.  Deficiency of dystrophin-associated proteins in Duchenne muscular dystrophy patients lacking COOH-terminal domains of dystrophin.

Authors:  K Matsumura; F M Tomé; V Ionasescu; J M Ervasti; R D Anderson; N B Romero; D Simon; D Récan; J C Kaplan; M Fardeau
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

7.  Immunogold localization of the 43-kDa dystroglycan at the plasma membrane in control and dystrophic human muscle.

Authors:  M J Cullen; J Walsh; L V Nicholson
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

Review 8.  Our trails and trials in the subsarcolemmal cytoskeleton network and muscular dystrophy researches in the dystrophin era.

Authors:  Eijiro Ozawa
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2010       Impact factor: 3.493

9.  Localization of dystrophin COOH-terminal domain by the fracture-label technique.

Authors:  S Squarzoni; P Sabatelli; M C Maltarello; A Cataldi; R di Primio; N M Maraldi
Journal:  J Cell Biol       Date:  1992-09       Impact factor: 10.539

10.  Direct visualization of the dystrophin network on skeletal muscle fiber membrane.

Authors:  V Straub; R E Bittner; J J Léger; T Voit
Journal:  J Cell Biol       Date:  1992-12       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.